First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study. (Q33775197)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study. |
scientific article |
Statements
First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study (English)
Ulrich Gatzemeier
Joachim von Pawel
Petr Zatloukal
Filippo de Marinis
Wilfried E E Eberhardt
Luis Paz-Ares
Karl-Maria Schumacher
Thomas Goddemeier
Kenneth J O'Byrne
17 December 2010